[Post-partum hypoglycaemia in a child to a father with HNF4A diabetes]

Ugeskrift for Laeger
|August 1, 2020
PubMed

Insights

Early detection and treatment of newborn hypoglycemia are crucial to prevent cognitive damage. This case highlights the importance of genetic screening in infants of parents with specific diabetes mutations.

Area of Science:

  • Genetics
  • Neonatology
  • Endocrinology

Background:

  • Newborn hypoglycemia can lead to permanent cognitive impairment if untreated.
  • Early feeding is standard practice, but does not always prevent hypoglycemia.
  • Genetic predisposition to diabetes, such as HNF4A mutations, can affect neonatal glucose regulation.

Observation:

  • A newborn presented with hypoglycemia two hours after birth, despite early feeding.
  • The infant's father has maturity-onset diabetes of the young Type 1, caused by an HNF4A gene mutation.
  • Proactive blood glucose monitoring was initiated due to the family history.

Findings:

  • The infant received supplemental feeding and recovered fully without lasting effects.
  • Genetic testing confirmed the infant carried the HNF4A gene mutation inherited from the father.
  • Early intervention based on genetic risk and clinical presentation was successful.

Implications:

  • This case underscores the importance of considering genetic factors in neonatal hypoglycemia.
  • Routine genetic screening in at-risk newborns can facilitate early diagnosis and management.
  • Prompt treatment prevents severe outcomes, emphasizing the link between genetics and neonatal metabolic health.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
676
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K